Skip to main content
October 17, 2018
Nutrasource is thrilled to announce the formation of a strategic alliance with AgMedica Bioscience Inc., a licensed producer of medical cannabis, to provide global regulatory, clinical research, and claims substantiation services to support the commercialization of cannabis-derived health products.
"We are very pleased to enter into this important strategic alliance with Nutrasource, whose approach, culture and values are optimally aligned with AgMedica's, as we aim to accelerate our ultimate goal of commercializing and providing access to differentiated cannabis products for the medicinal, pharmaceutical and health and wellness sectors," said Dr. Trevor Henry, CEO of AgMedica. "Our relationship with Nutrasource is expected to help AgMedica bring new cannabis products to market with trust and confidence, backed by strong science and regulatory credibility."
"We're thrilled that AgMedica has chosen Nutrasource to fulfill the global regulatory and clinical trial needs across its unique portfolio of products being advanced for commercialization,” says William Rowe, President and CEO of Nutrasource. “AgMedica's leadership role in the development of cannabis and cannabis-derived products is demonstrated by their methodical approach and thorough investment in research to confirm the therapeutic value of new and important medicines."